Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution

por Di Nunno, Vincenzo, Gatto, Lidia, Tosoni, Alicia, Bartolini, Stefania, Franceschi, Enrico
Publicado 2023

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open

por Gatto, Lidia, Di Nunno, Vincenzo, Tosoni, Alicia, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico
Publicado 2023

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

por Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2022

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance

por Di Nunno, Vincenzo, Franceschi, Enrico, Tosoni, Alicia, Gatto, Lidia, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2022

Tumor-Associated Microenvironment of Adult Gliomas: A Review

por Di Nunno, Vincenzo, Franceschi, Enrico, Tosoni, Alicia, Gatto, Lidia, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2022

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

por Gatto, Lidia, Ricciotti, Ilaria, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico
Publicado 2023

Olfactory neuroblastoma: diagnosis, management, and current treatment options

por Tosoni, Alicia, Di Nunno, Vincenzo, Gatto, Lidia, Corradi, Giacomo, Bartolini, Stefania, Ranieri, Lucia, Franceschi, Enrico
Publicado 2023

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?

por Di Nunno, Vincenzo, Aprile, Marta, Gatto, Lidia, Tosoni, Alicia, Ranieri, Lucia, Bartolini, Stefania, Franceschi, Enrico
Publicado 2023

Glioblastoma: Emerging Treatments and Novel Trial Designs

por Di Nunno, Vincenzo, Franceschi, Enrico, Tosoni, Alicia, Gatto, Lidia, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2021

Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER...

por Dieci, Maria Vittoria, Bisagni, Giancarlo, Bartolini, Stefania, Frassoldati, Antonio, Vicini, Roberto, Balduzzi, Sara, D’amico, Roberto, Conte, Pierfranco, Guarneri, Valentina
Publicado 2023

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets

por Maggio, Ilaria, Franceschi, Enrico, Di Nunno, Vincenzo, Gatto, Lidia, Tosoni, Alicia, Angelini, Daniele, Bartolini, Stefania, Lodi, Raffaele, Brandes, Alba Ariela
Publicado 2021

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology

por Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Tonon, Caterina, Lodi, Raffaele, Agati, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2022

Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial

por Dieci, Maria Vittoria, Bisagni, Giancarlo, Bartolini, Stefania, Frassoldati, Antonio, Vicini, Roberto, Balduzzi, Sara, D’amico, Roberto, Conte, Pierfranco, Guarneri, Valentina
Publicado 2023

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review

por Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Maggio, Ilaria, Tonon, Caterina, Lodi, Raffaele, Agati, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2021

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma

por Franceschi, Enrico, De Biase, Dario, Di Nunno, Vincenzo, Pession, Annalisa, Tosoni, Alicia, Gatto, Lidia, Tallini, Giovanni, Visani, Michela, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Publicado 2021

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Tosoni, Alicia, Eoli, Marica, Lombardi, Giuseppe, Clavarezza, Matteo, Paccapelo, Alexandro, Bartolini, Stefania, Cirillo, Luigi, Agati, Raffaele, Franceschi, Enrico
Publicado 2017

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma

por de Biase, Dario, Genestreti, Giovenzio, Visani, Michela, Acquaviva, Giorgia, Di Battista, Monica, Cavallo, Giovanna, Paccapelo, Alexandro, Cancellieri, Alessandra, Trisolini, Rocco, Degli Esposti, Roberta, Bartolini, Stefania, Pession, Annalisa, Tallini, Giovanni, Brandes, Alba A.
Publicado 2017